Skip to main content
Home
Issues
2023
June 2023 - Vol 16 No 1
2022
December - Vol 15 No 4
September - Vol 15 No 3
June - Vol 15 No 2
March - Vol 15 No 1 - Online Only
Issue Archive
Special Issues
December 2023 Vol 16, Payers' Guide to FDA Updates
Supplements
Special Issue Archive
Topics
Conference Correspondent
ESMO 2023 - Small Cell Lung Cancer
Web Exclusives
Web Exclusive Topics
All Web Exclusives
Select Drug Profiles
FDA Approvals
In the News
Press Releases
Videos
Interview with the Innovators
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Reprints
Subscribe
Home
Issues
2023
June 2023 - Vol 16 No 1
2022
December - Vol 15 No 4
September - Vol 15 No 3
June - Vol 15 No 2
March - Vol 15 No 1 - Online Only
Issue Archive
Special Issues
December 2023 Vol 16, Payers' Guide to FDA Updates
Supplements
Special Issue Archive
Topics
Conference Correspondent
ESMO 2023 - Small Cell Lung Cancer
Web Exclusives
Web Exclusive Topics
All Web Exclusives
Select Drug Profiles
FDA Approvals
In the News
Press Releases
Videos
Interview with the Innovators
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Reprints
Raymond Y. Cheung, PhD
Clinical Director
Pain Therapeutic Area Sub-Team
Pfizer Clinical Sciences
Pfizer, New York, NY
Clinical Director
Pain Therapeutic Area Sub-Team
Pfizer Clinical Sciences
Pfizer, New York, NY
Authored Items
Healthcare Utilization and Costs of Knee or Hip Replacements versus Pain-Relief Injections
Margaret K. Pasqule, PhD
,
Steve Miff, PhD
,
Anthony M. Louder, PhD, RPh
,
Raymond Y. Cheung, PhD
,
Andrew T. Reiners, MD
,
Robert J. Sanchez, PhD
,
Veerainder Goli, MD, MBA, DFAPA
,
Jack Mardekian, PhD
October 2015 Vol 8, No 7
in
Business
Last modified: October 19, 2015